Ironwood Pharmaceuticals, Inc. (IRWD)

Last Closing Price: 0.63 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Ironwood Pharmaceuticals, Inc. (IRWD) had Net Income of $-37.39M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$41.14M
Net Income
$-37.39M
--
$41.14M
$70.25M
$-29.11M
$-7.16M
$-36.27M
$-36.27M
$-37.39M
$-37.39M
$-37.39M
$-37.39M
$-29.11M
$-28.63M
160.97M
160.97M
$-0.23
$-0.23
Balance Sheet Financials
$160.58M
$4.26M
$166.63M
$327.21M
$48.10M
$584.16M
$613.17M
$661.27M
$-334.05M
$-336.71M
$-334.05M
161.81M
Cash Flow Statement Financials
$19.95M
$-0.03M
$0.01M
$88.56M
$108.48M
$19.92M
$5.29M
--
--
Fundamental Metrics & Ratios
3.34
--
--
2.34
-1.75
100.00%
-70.75%
-70.75%
--
-88.16%
-90.87%
$19.92M
--
--
--
0.13
--
1.03
86.99
11.19%
11.10%
-11.43%
-14.95%
$-2.06
$0.12
$0.12